MedicalResearch.com |
New Drug Shows Promise for Rare Blood Cancers
U.S. News & World Report WEDNESDAY, June 29, 2016 (HealthDay News) -- An experimental drug called midostaurin may reverse organ damage in people with certain rare, fatal blood cancers, an early clinical trial finds. Researchers found that the drug at least partly reversed ... Novartis (NVS) Announces Publication of Positive PKC412 ORR Data in Advanced SM Group of rare blood cancers respond to new treatment pioneered by Stanford physician |
from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNFo3EGUzXQoZWRDaGrMfk5sjNqgCQ&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779144079157&ei=Z4B0V7iiJoqQ3QGWnaa4Dw&url=http://health.usnews.com/health-care/articles/2016-06-29/new-drug-shows-promise-for-rare-blood-cancers
via IFTTT
No comments:
Post a Comment